Healthtech Startups

CAIRE develops and manufactures oxygen delivery equipment and services for medical and commercial applications, including products under its AirSep, HELiOS, and SeQual brands. Its customers include hospitals and military personnel who rely on high-performance oxygen delivery products.

1 investor

Cairns Health develops voice-activated software and radar-based monitoring devices for patients with chronic conditions, delivering medication reminders, symptom assessments, and activity tracking to coordinate care teams and reduce clinical costs.

1 investor

Caitech operates a mobile app that matches nursing-care and healthcare workers with single-day, short-term shifts, letting qualified staff (caregivers, nurses, and related certificate holders) apply in about a minute without interviews or resumes. The service handles direct day-labor employment contracts with facilities and offers same-day pay, serving Japan's care and medical staffing market.

1 investor

Cakehealth.com is a health information and product-review website presented as merged with Dualdiagnosis.org, covering topics such as CBD, medical trends, mental and physical health, and supplement product tests. The site publishes reviews and buying guides on health-related products for general consumers.

1 investor

1 investor

Calder Biosciences develops protein-based subunit vaccines using its 3D-Vaxlock technology, which uses dityrosine crosslinking to lock immunogens into the shape they hold on a virus surface for improved antibody responses. Its engineered immunogens aim to offer better safety, efficacy, thermostability, and reduced cold chain requirements against infectious diseases.

1 investor

CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.

1 investor

Calgary Scientific develops a mobile visualization platform for healthcare professionals that enables secure access to 2D/3D medical images for collaboration and diagnosis across any device without duplicating source files.

1 investor

Calistoga Pharmaceuticals is a pharmaceutical company. The available page content does not describe its therapeutic focus or products.

1 investor

Calla Lily Clinical Care is a women's health company developing intravaginal drug delivery products based on its proprietary Callavid platform device, targeting IVF, prevention of preterm birth and miscarriage, delivery of live biotherapeutics to restore the vaginal microbiome, and biomarker sample collection for diagnostics such as endometriosis. Its FDA-cleared device technology serves the women's health and medical device market.

1 investor

Callara is a platform for 340B pharmacies, FQHCs, and clinics that logs drug decisions at the point of care, tracks them to the pharmacy fill, and verifies capture. It surfaces eligible OTC benefits, provides drug price intelligence factoring in 340B, patient assistance, formularies, and sliding scales, and offers a unified patient-messaging hub with AI-assisted responses.

1 investor

Holo is a personalized health platform that consolidates lab data, wearable insights, and imaging into a single actionable dashboard to help individuals proactively manage their wellbeing and extend healthspan. The platform serves consumers seeking preventive health management and longevity optimization in Europe.

1 investor

calmea builds a contactless sensing module hidden inside a bed's structure that measures physiological signals such as heart rate, breathing rate, sleep stages and movements along with room conditions like temperature, humidity, air quality and light. It provides this sleep-tracking intelligence layer to bedding manufacturers to integrate into their products, connecting with smart home devices to adjust lighting, sound, climate and wake-up timing.

1 investor

Calocurb is a natural, plant-based appetite suppressant capsule containing a patented hop extract that activates GLP-1 and other satiety hormones to reduce hunger and support weight management. The product is designed as a prescription-free alternative backed by clinical research and available in New Zealand.

1 investor

Calosense provides a comprehensive weight loss platform offering clinical guidance and remote patient monitoring for GLP-1 therapy management.

1 investor

Calycia Bioscience is a biotechnology company developing engineered macrophage cell therapies delivered locally into the brain to target aggressive solid tumors of the central nervous system. Its pipeline focuses on glioblastoma and melanoma brain metastasis within CNS oncology.

1 investor

Calyx Health operates Mabel, a platform for voluntary alignment that automates outreach, response processing, analytics, and compliance for Accountable Care Organizations (ACOs) and health plans. It sends provider-branded communications to Medicare beneficiaries to grow enrollment in value-based care programs such as LEAD, ACO REACH, and GUIDE.

1 investor

Calyxha is a biotech company developing novel small molecule anti-inflammatory drugs for multiple inflammatory diseases. Its lead product, CAL-4, is in preclinical development as an alternative to corticosteroids for asthma.

1 investor

Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared. The company serves urologists and patients seeking routine, single-treatment kidney stone management.

1 investor

Cambia Health Solutions is a not-for-profit healthcare and technology company that operates regional health plans offering local, affordable coverage and member support, and uses data and AI to make healthcare simpler and more accessible. It also makes strategic investments in healthcare innovations and runs community health initiatives, primarily serving members in the U.S. Pacific Northwest.

1 investor

Cambio is a leading provider of electronic health record systems and eHealth solutions in the Nordic region, serving healthcare professionals and regions across Sweden. The company develops interoperable digital healthcare systems designed to improve patient care through data-driven, seamlessly connected health and social care delivery.

1 investor

Cambrex provides pharmaceutical supply chain management and manufacturing services focused on supply chain resilience through dual sourcing and contingency planning to ensure reliable product delivery during disruptions.

1 investor

The company develops a 6-base sequencing platform (duet evoC) that simultaneously profiles methylation (5mC, 5hmC), genetic variants, and fragmentomics from a single cfDNA sample. Its multi-modal liquid biopsy technology is aimed at biomarker discovery and cancer detection for genomics and life sciences research.

1 investor

Cambridge Orthopaedic Labs develops non-invasive trauma fixation technologies for orthopaedic trauma surgery, including a platform for non-surgical management of fractures used by surgeons and healthcare providers. The company conducts research in Cambridge, UK and runs headquarters and sales operations in Pennsylvania, US.

1 investor